We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
-15.11%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$96.6M
AUM Growth
-$25.4M
(-21%)
Cap. Flow
+$324K
Cap. Flow
% of AUM
0.34%
Top 10 Holdings %
Top 10 Hldgs %
32.65%
Holding
115
New
5
Increased
35
Reduced
28
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABTC
American Bitcoin Corp
ABTC
|
+$1.24M |
| 2 |
Magnite
MGNI
|
+$1.21M |
| 3 |
Fortress Biotech
FBIO
|
+$650K |
| 4 |
NeoGenomics
NEO
|
+$477K |
| 5 |
SRXH
SRX Global
SRXH
|
+$412K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATRS
Antares Pharma, Inc.
ATRS
|
+$1.97M |
| 2 |
LeMaitre Vascular
LMAT
|
+$1.95M |
| 3 |
International Flavors & Fragrances
IFF
|
+$563K |
| 4 |
AT&T
T
|
+$223K |
| 5 |
Costco
COST
|
+$219K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 54.22% |
| 2 | Technology | 19.39% |
| 3 | Communication Services | 8.2% |
| 4 | Consumer Staples | 7.55% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Apple
AAPL
$4.54T
| $636K | 0.66% |
4,650
-300
| -6% | -$45.4K |
|
|
SMED
52
DELISTED
Sharps Compliance Corp
SMED
| $552K | 0.57% |
189,160
-29,295
| -13% | -$122K |
|
|
BIOL
53
DELISTED
Biolase, Inc.
BIOL
| $542K | 0.56% |
1,183
-43
| -4% | -$23.6K |
|
|
PRFT
54
DELISTED
Perficient Inc
PRFT
| $523K | 0.54% |
5,700
| – | – |
|
55
Option Care Health
OPCH
$3.45B
| $514K | 0.53% |
18,500
-2,700
| -13% | -$76.8K |
|
56
AquaBounty Technologies
AQB
$4.66M
| $510K | 0.53% |
14,925
+950
| +7% | +$29K |
|
57
CVS Health
CVS
$133B
| $497K | 0.51% |
5,359
| – | – |
|
58
Donaldson
DCI
$10.9B
| $480K | 0.5% |
9,967
+400
| +4% | +$20.1K |
|
59
Fastenal
FAST
$54.7B
| $479K | 0.5% |
19,200
| – | – |
|
60
Village Farms International
VFF
$234M
| $466K | 0.48% |
178,550
-3,500
| -2% | -$12.7K |
|
61
Rockwell Medical
RMTI
$28.4M
| $458K | 0.47% |
35,505
-2,042
| -5% | -$54K |
|
62
BioLife Solutions
BLFS
$1.53B
| $442K | 0.46% |
32,000
+11,000
| +52% | +$161K |
|
63
US Bancorp
USB
$98.2B
| $410K | 0.42% |
8,917
| – | – |
|
64
Johnson & Johnson
JNJ
$618B
| $408K | 0.42% |
2,300
| – | – |
|
65
NXP Semiconductors
NXPI
$57.8B
| $363K | 0.38% |
2,450
| – | – |
|
|
CSII
66
DELISTED
Cardiovascular Systems, Inc.
CSII
| $362K | 0.37% |
25,200
+750
| +3% | +$13K |
|
67
CryoPort
CYRX
$761M
| $356K | 0.37% |
11,500
| – | – |
|
|
RYM
68
RYTHM Inc
RYM
$39.5M
| $353K | 0.37% |
60
+20
| +50% | +$170K |
|
69
LifeVantage
LFVN
$81.1M
| $346K | 0.36% |
79,613
| – | – |
|
|
ABTC
70
American Bitcoin Corp
ABTC
$403M
| $300K | 0.31% |
+72
| New | +$1.24M |
|
|
UPH
71
DELISTED
UpHealth, Inc.
UPH
| $293K | 0.3% |
49,479
-5,237
| -10% | -$40.7K |
|
72
ANI Pharmaceuticals
ANIP
$1.8B
| $280K | 0.29% |
9,426
| – | – |
|
73
Lantronix
LTRX
$240M
| $269K | 0.28% |
50,000
| – | – |
|
74
Baxter International
BAX
$13.5B
| $257K | 0.27% |
4,009
| – | – |
|
|
BNC
75
CEA Industries
BNC
$110M
| $245K | 0.25% |
16,225
-442
| -3% | -$8.02K |
|
Similar funds
SVP
PWP
BF
SFG
HWMG
FTEA
WT
BAM
Perkins Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Perkins Capital Management held 115 positions worth $96.6M, down 21% from $122M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Perkins Capital Management's Q2 2022 filing shows 5 new, 35 increased, 28 reduced and 10 closed positions. Its largest new stake was American Bitcoin Corp: 72 shares worth $300K. The largest sale was Antares Pharma, Inc., an estimated $1.97M.
By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 56% a quarter earlier, followed by Technology and Communication Services.
- Perkins Capital Management's largest Q2 2022 buy was American Bitcoin Corp: 72 shares worth $300K.
- Perkins Capital Management added most to Magnite in Q2 2022, an estimated $1.21M increase.
- Perkins Capital Management's biggest Q2 2022 reduction was AT&T, cutting an estimated $223K.
- Perkins Capital Management fully exited Antares Pharma, Inc. in Q2 2022, selling an estimated $1.97M.
- Perkins Capital Management's ten largest holdings make up 33% of its $96.6M portfolio in Q2 2022.
- Perkins Capital Management opened 5 new positions and closed 10 in Q2 2022.
- Perkins Capital Management's portfolio value fell 21% quarter-over-quarter to $96.6M.
Based on Perkins Capital Management's 13F filing for Q2 2022, filed 29 Jul 2022.